Ralph Dr. Kern - Net Worth and Insider Trading
Ralph Dr. Kern Net Worth
The estimated net worth of Ralph Dr. Kern is at least $28,393 dollars as of 2024-09-20. Ralph Dr. Kern is the COO and Chief Medical Officer of Brainstorm Cell Therapeutics Inc and owns about 115,655 shares of Brainstorm Cell Therapeutics Inc (BCLI) stock worth over $28,393. Details can be seen in Ralph Dr. Kern's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ralph Dr. Kern has not made any transactions after 2019-12-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ralph Dr. Kern
Ralph Dr. Kern Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ralph Dr. Kern owns 1 companies in total, including Brainstorm Cell Therapeutics Inc (BCLI) .
Click here to see the complete history of Ralph Dr. Kern’s form 4 insider trades.
Insider Ownership Summary of Ralph Dr. Kern
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCLI | Brainstorm Cell Therapeutics Inc | 2019-12-24 | COO and Chief Medical Officer |
Ralph Dr. Kern Latest Holdings Summary
Ralph Dr. Kern currently owns a total of 1 stock. Ralph Dr. Kern owns 115,655 shares of Brainstorm Cell Therapeutics Inc (BCLI) as of December 24, 2019, with a value of $28,393.
Latest Holdings of Ralph Dr. Kern
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCLI | Brainstorm Cell Therapeutics Inc | 2019-12-24 | 115,655 | 0.25 | 28,393 |
Holding Weightings of Ralph Dr. Kern
Ralph Dr. Kern Form 4 Trading Tracker
According to the SEC Form 4 filings, Ralph Dr. Kern has made a total of 1 transactions in Brainstorm Cell Therapeutics Inc (BCLI) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Brainstorm Cell Therapeutics Inc is the acquisition of 3,000 shares on December 24, 2019, which cost Ralph Dr. Kern around $11,640.
Insider Trading History of Ralph Dr. Kern
- 1
Ralph Dr. Kern Trading Performance
GuruFocus tracks the stock performance after each of Ralph Dr. Kern's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ralph Dr. Kern is 23.21%. GuruFocus also compares Ralph Dr. Kern's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ralph Dr. Kern within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ralph Dr. Kern's insider trading performs compared to the benchmark.
Performance of Ralph Dr. Kern
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.09 | | | | | |
| Relative Return to S&P 500(%) | 1.63 | | | | | |
Ralph Dr. Kern Ownership Network
Ralph Dr. Kern Owned Company Details
What does Brainstorm Cell Therapeutics Inc do?
Who are the key executives at Brainstorm Cell Therapeutics Inc?
Ralph Dr. Kern is the COO and Chief Medical Officer of Brainstorm Cell Therapeutics Inc. Other key executives at Brainstorm Cell Therapeutics Inc include Chief Executive Officer Chaim Lebovits , EVP & Head Global Clin Research Stacy Lindborg , and Chief Medical Officer Kirk Taylor .
Brainstorm Cell Therapeutics Inc (BCLI) Insider Trades Summary
Over the past 18 months, Ralph Dr. Kern made no insider transaction in Brainstorm Cell Therapeutics Inc (BCLI). Other recent insider transactions involving Brainstorm Cell Therapeutics Inc (BCLI) include a net purchase of 566,372 shares made by Chaim Lebovits , a net sale of 63,000 shares made by , and a net purchase of 11,500 shares made by Stacy Lindborg .
In summary, during the past 3 months, insiders sold 63,000 shares of Brainstorm Cell Therapeutics Inc (BCLI) in total and bought 0 shares, with a net sale of 63,000 shares. During the past 18 months, 63,000 shares of Brainstorm Cell Therapeutics Inc (BCLI) were sold and 577,872 shares were bought by its insiders, resulting in a net purchase of 514,872 shares.
Brainstorm Cell Therapeutics Inc (BCLI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Brainstorm Cell Therapeutics Inc Insider Transactions
Ralph Dr. Kern Mailing Address
Above is the net worth, insider trading, and ownership report for Ralph Dr. Kern. You might contact Ralph Dr. Kern via mailing address: C/o Brainstorm Cell Therapeutics, Inc., 3 University Plaza Drive, Suite 320, Hackensack Nj 07601.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
